Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing, collaboration and partnerships

The Latin American Center for Pediatric Oncology Nursing Education

(2013) Sara W. Day et al.   CANCER NURSING

Reducing delayed intensification therapy in childhood ALL

(2013) Ching-Hon Pui   LANCET ONCOLOGY

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

(2013) Ajay Vora et al.   LANCET ONCOLOGY

New policies to address the global burden of childhood cancers

(2013) Richard Sullivan et al.   LANCET ONCOLOGY

Paediatric cancer in low-income and middle-income countries

(2013) Ian Magrath et al.   LANCET ONCOLOGY

The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi

(2012) N. Bhakta et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala

(2012) Federico Antillon et al.   PEDIATRIC BLOOD & CANCER

Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health

(2011) Kirsten K Ness et al.   Expert Review of Hematology

Prophylactic cranial irradiation: going, going, gone

(2009) Ching-Hon Pui   LANCET ONCOLOGY

Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

(2009) Ching-Hon Pui et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal

(2009) Stephen P. Hunger et al.   PEDIATRIC BLOOD & CANCER

Cost of childhood acute lymphoblastic leukemia care in Shanghai, China

(2009) Yin Liu et al.   PEDIATRIC BLOOD & CANCER

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

(2008) M. J. Borowitz et al.   BLOOD

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

(2008) A. Moricke et al.   BLOOD

Long-Term Results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: Insight on the Prognostic Value of DNA Index in the Framework of Berlin-Frankfurt-Muenster–Based Chemotherapy

(2008) Maurizio Aricò et al.   JOURNAL OF CLINICAL ONCOLOGY

Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study

(2008) Raul C Ribeiro et al.   LANCET ONCOLOGY

Treatment of acute lymphoblastic leukemia in low- and middle-income countries: Challenges and opportunities

(2008) Raul Ribeiro et al.   LEUKEMIA & LYMPHOMA